Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,233 | 23 | 70.1% |
| Travel and Lodging | $456.80 | 3 | 26.0% |
| Education | $69.00 | 1 | 3.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $631.03 | 5 | $0 (2019) |
| Covidien LP | $305.72 | 6 | $0 (2020) |
| ABBVIE INC. | $229.27 | 3 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $126.92 | 1 | $0 (2023) |
| Aries Pharmaceuticals, Inc. | $124.12 | 1 | $0 (2018) |
| ERBE USA Inc | $89.47 | 1 | $0 (2017) |
| Digestive Care, Inc. | $81.58 | 1 | $0 (2019) |
| Synergy Pharmaceuticals Inc | $66.71 | 4 | $0 (2018) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $46.23 | 2 | $0 (2018) |
| Otsuka America Pharmaceutical, Inc. | $24.00 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $14.70 | 1 | ABBVIE INC. ($14.70) |
| 2023 | $148.34 | 2 | Janssen Scientific Affairs, LLC ($126.92) |
| 2020 | $19.71 | 1 | Covidien LP ($19.71) |
| 2019 | $894.51 | 8 | Boston Scientific Corporation ($631.03) |
| 2018 | $471.02 | 12 | Aries Pharmaceuticals, Inc. ($124.12) |
| 2017 | $210.59 | 3 | AbbVie, Inc. ($100.23) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/11/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/08/2023 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: Immunology | ||||||
| 02/14/2023 | Janssen Scientific Affairs, LLC | STELARA (Biological) | Food and Beverage | In-kind items and services | $126.92 | General |
| Category: Immunology | ||||||
| 03/11/2020 | Covidien LP | Beacon (Device) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: Endoscopic Ultrasound | ||||||
| 11/05/2019 | Boston Scientific Corporation | GENERAL THERAPIES (Device) | Travel and Lodging | Cash or cash equivalent | $70.94 | General |
| Category: THERAPIES | ||||||
| 11/05/2019 | Boston Scientific Corporation | GENERAL THERAPIES (Device) | Travel and Lodging | Cash or cash equivalent | $60.00 | General |
| Category: THERAPIES | ||||||
| 11/05/2019 | Boston Scientific Corporation | GENERAL THERAPIES (Device) | Food and Beverage | Cash or cash equivalent | $11.70 | General |
| Category: THERAPIES | ||||||
| 10/02/2019 | Boston Scientific Corporation | SPYGLASS (Device) | Travel and Lodging | In-kind items and services | $325.86 | General |
| Category: BILIARY DEVICES | ||||||
| 10/02/2019 | Boston Scientific Corporation | SPYGLASS (Device) | Food and Beverage | In-kind items and services | $162.53 | General |
| Category: BILIARY DEVICES | ||||||
| 05/29/2019 | Digestive Care, Inc. | Pertzye (Drug), Pertzye, Pertzye | Food and Beverage | Cash or cash equivalent | $81.58 | General |
| Category: Gastroenterology | ||||||
| 03/18/2019 | Covidien LP | — | Food and Beverage | In-kind items and services | $98.82 | General |
| 03/18/2019 | Covidien LP | — | Food and Beverage | In-kind items and services | $83.08 | General |
| 12/14/2018 | Covidien LP | Bravo (Device) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: GI Solutions | ||||||
| 11/02/2018 | Covidien LP | Endo GIA (Device) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Devices | ||||||
| 11/01/2018 | Aries Pharmaceuticals, Inc. | ELEVIEW (Device) | Food and Beverage | In-kind items and services | $124.12 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/01/2018 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: NEPHROLOGY | ||||||
| 10/29/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $114.34 | General |
| Category: Immunology | ||||||
| 08/16/2018 | Synergy Pharmaceuticals Inc | Trulance (Drug) | Food and Beverage | In-kind items and services | $11.58 | General |
| Category: Gastroenterology | ||||||
| 08/13/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $27.14 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/19/2018 | Synergy Pharmaceuticals Inc | Trulance (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Gastroenterology | ||||||
| 07/09/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/19/2018 | Shire North American Group Inc | GATTEX (Drug) | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: INTERNAL MEDICINE | ||||||
| 02/08/2018 | Synergy Pharmaceuticals Inc | Trulance (Drug) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: Gastroenterology | ||||||
| 01/13/2018 | Covidien LP | PillCam (Device) | Education | In-kind items and services | $69.00 | General |
| Category: GIH | ||||||
| 08/16/2017 | Synergy Pharmaceuticals Inc | Trulance (Drug) | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 852 | 949 | $458,746 | $97,254 |
| 2022 | 5 | 191 | 203 | $122,270 | $23,006 |
| 2021 | 5 | 182 | 200 | $103,437 | $23,778 |
| 2020 | 3 | 47 | 47 | $21,985 | $5,274 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 239 | 242 | $175,208 | $45,783 | 26.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 159 | 164 | $97,088 | $10,121 | 10.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 58 | 60 | $20,870 | $7,669 | 36.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 56 | 88 | $19,082 | $7,663 | 40.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 62 | 99 | $12,546 | $5,897 | 47.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 51 | 53 | $12,857 | $5,212 | 40.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 40 | 52 | $9,138 | $4,650 | 50.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 123 | 123 | $84,501 | $4,213 | 5.0% |
| 43251 | Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare | Facility | 2023 | 17 | 18 | $13,662 | $2,046 | 15.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $4,685 | $1,692 | 36.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 19 | $2,907 | $1,214 | 41.7% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 13 | 14 | $6,202 | $1,094 | 17.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 81 | 82 | $69,083 | $15,620 | 22.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 60 | 63 | $30,742 | $3,879 | 12.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 17 | 25 | $2,985 | $1,721 | 57.7% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 14 | 14 | $5,762 | $1,131 | 19.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 19 | 19 | $13,698 | $655.42 | 4.8% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 66 | 68 | $57,942 | $13,069 | 22.6% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 54 | 59 | $27,729 | $4,776 | 17.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 28 | 39 | $3,429 | $2,738 | 79.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 18 | 18 | $2,846 | $1,847 | 64.9% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 16 | 16 | $11,491 | $1,349 | 11.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope | Facility | 2020 | 14 | 14 | $11,816 | $2,763 | 23.4% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 19 | 19 | $8,835 | $1,633 | 18.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 14 | 14 | $1,334 | $878.36 | 65.8% |
About Dr. Abby Sapp, D.O
Dr. Abby Sapp, D.O is a Internal Medicine healthcare provider based in Rockport, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/05/2013. The National Provider Identifier (NPI) number assigned to this provider is 1538400247.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Abby Sapp, D.O has received a total of $1,759 in payments from pharmaceutical and medical device companies, with $14.70 received in 2024. These payments were reported across 27 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,233).
As a Medicare-enrolled provider, Sapp has provided services to 1,272 Medicare beneficiaries, totaling 1,399 services with total Medicare billing of $149,312. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Gastroenterology, Hospitalist
- Location Rockport, ME
- Active Since 03/05/2013
- Last Updated 09/11/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1538400247
Products in Payments
- SPYGLASS (Device) $488.39
- GENERAL THERAPIES (Device) $142.64
- STELARA (Biological) $126.92
- ELEVIEW (Device) $124.12
- Humira (Biological) $114.34
- Creon (Drug) $100.23
- Hybrid Knife (Device) $89.47
- Pertzye (Drug) $81.58
- PillCam (Device) $69.00
- Trulance (Drug) $66.71
- XIFAXAN (Drug) $46.23
- JYNARQUE (Drug) $24.00
- REMICADE (Biological) $21.42
- Endo GIA (Device) $20.00
- Beacon (Device) $19.71
- Bravo (Device) $15.11
- LINZESS (Drug) $14.70
- GATTEX (Drug) $12.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Rockport
Alexander Abud, Md, MD
Internal Medicine — Payments: $103,026
Dr. Russell Riehl, Md, Mph, MD, MPH
Internal Medicine — Payments: $2,212
Dr. Ronald Bruce, D.o, D.O
Internal Medicine — Payments: $1,388
Heather Arsenault, Do, DO
Internal Medicine — Payments: $128.48
Galina Kazanikova, Md, MD
Internal Medicine — Payments: $125.76
David Kern, M.d, M.D
Internal Medicine — Payments: $110.97